Nitisinone attenuates progression of aortic stenosis in patients with alkaptonuria: an analysis of the SONIA 2 study

Back

ESC Professional Premium Access

Nitisinone attenuates progression of aortic stenosis in patients with alkaptonuria: an analysis of the SONIA 2 study

Session: New molecular insights into valvular heart disease

Topic: Aortic Valve Stenosis

Speaker: Doctor C. Bruce (Liverpool, GB)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Callum Bruce

The Royal Liverpool University Hospital, Liverpool (United Kingdom of Great Britain & Northern Ireland)

0 follower

8 more presentations in this session

Aortic valve stenosis augments long noncoding RNA H19 to govern angiogenic responses and phenotypes of valvular endothelial cell through endothelial to mesenchymal transition

Speaker: Doctor M. Hosen (Bonn, DE)

Aortic valve disease augments vesicular microRNA-145-5p to regulate the calcification of valvular interstitial cells via cellular crosstalk

Speaker: Doctor M. Hosen (Bonn, DE)

Access

Abstract

Slides

Effects of empagliflozin on myocardial transcriptome in rats with aortic stenosis-induced heart failure

Speaker: Professor M. Okoshi (Botucatu, BR)

Impact of plasma from patients with severe aortic stenosis on valvular endothelial cells

Speaker: Doctor A. Trimaille (Strasbourg, FR)

Paired single-cell RNA sequencing and T cell receptor sequencing reveals both pro- and anti-inflammatory roles of T cells in patients with calcific aortic valve disease

Speaker: Miss X. Zhang (Wuhan, CN)

Access the full session

New molecular insights into valvular heart disease

Speakers: Doctor C. Bruce, Doctor M. Hosen, Doctor M. Hosen, Professor M. Okoshi, Doctor A. Trimaille...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources